JP2016520068A5 - - Google Patents

Download PDF

Info

Publication number
JP2016520068A5
JP2016520068A5 JP2016513108A JP2016513108A JP2016520068A5 JP 2016520068 A5 JP2016520068 A5 JP 2016520068A5 JP 2016513108 A JP2016513108 A JP 2016513108A JP 2016513108 A JP2016513108 A JP 2016513108A JP 2016520068 A5 JP2016520068 A5 JP 2016520068A5
Authority
JP
Japan
Prior art keywords
scaffold
stem cells
abcb5
wound healing
population
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016513108A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016520068A (ja
JP6600299B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/037435 external-priority patent/WO2014182994A1/en
Publication of JP2016520068A publication Critical patent/JP2016520068A/ja
Publication of JP2016520068A5 publication Critical patent/JP2016520068A5/ja
Application granted granted Critical
Publication of JP6600299B2 publication Critical patent/JP6600299B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016513108A 2013-05-10 2014-05-09 創傷治癒および組織工学 Active JP6600299B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361822134P 2013-05-10 2013-05-10
US61/822,134 2013-05-10
PCT/US2014/037435 WO2014182994A1 (en) 2013-05-10 2014-05-09 Wound healing and tissue engineering

Publications (3)

Publication Number Publication Date
JP2016520068A JP2016520068A (ja) 2016-07-11
JP2016520068A5 true JP2016520068A5 (cg-RX-API-DMAC7.html) 2017-06-22
JP6600299B2 JP6600299B2 (ja) 2019-10-30

Family

ID=51867763

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016513108A Active JP6600299B2 (ja) 2013-05-10 2014-05-09 創傷治癒および組織工学

Country Status (12)

Country Link
US (2) US11446331B2 (cg-RX-API-DMAC7.html)
EP (2) EP2994173B1 (cg-RX-API-DMAC7.html)
JP (1) JP6600299B2 (cg-RX-API-DMAC7.html)
KR (1) KR102319899B1 (cg-RX-API-DMAC7.html)
CN (1) CN105517587B (cg-RX-API-DMAC7.html)
AU (1) AU2014262590B2 (cg-RX-API-DMAC7.html)
BR (1) BR112015028193B8 (cg-RX-API-DMAC7.html)
CA (1) CA2911232C (cg-RX-API-DMAC7.html)
DK (1) DK2994173T3 (cg-RX-API-DMAC7.html)
ES (1) ES2892403T3 (cg-RX-API-DMAC7.html)
MX (1) MX378814B (cg-RX-API-DMAC7.html)
WO (1) WO2014182994A1 (cg-RX-API-DMAC7.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1290028E (pt) 2000-06-05 2010-03-12 Brigham & Womens Hospital Um gene que codifica um homólogo de glicoproteína p humana de resistência a múltiplos fármacos, situado no cromossoma 7p15-21 e suas utilizações
DK2035549T3 (da) 2006-05-31 2014-10-13 Childrens Medical Center Abcb5-positive mesenkymale stamceller som immunmodulatorer
EP2155248B1 (en) 2007-04-12 2015-06-10 The Brigham and Women's Hospital, Inc. Targeting abcb5 for cancer therapy
US11542328B2 (en) 2008-11-14 2023-01-03 The Brigham And Women's Hospital, Inc. Therapeutic and diagnostic methods relating to cancer stem cells
EP3734281A3 (en) 2008-11-14 2021-01-27 The Brigham and Women's Hospital, Inc. Therapeutic and diagnostic methods relating to cancer stem cells
DK2964238T3 (da) 2013-02-19 2021-03-22 Childrens Medical Center Abcb5(+) stem cells for treating ocular disease
KR102319899B1 (ko) 2013-05-10 2021-11-01 칠드런'즈 메디컬 센터 코포레이션 상처 치유 및 조직 공학
DK3212247T3 (da) * 2014-10-31 2021-06-28 The Administrators Of The Tulane Educational Fund Kirurgiske implantater til erstatning af brystvorte og areola eller beskadiget epidermis
US20200038248A1 (en) * 2016-10-05 2020-02-06 Temple University- Of The Commonwealth System Of Higher Education Negative Pressure Enhanced Cellular Infiltration
CN107050521B (zh) * 2017-04-27 2020-10-09 天新福(北京)医疗器材股份有限公司 一种双层胶原真皮支架及其制备方法
WO2019210109A1 (en) * 2018-04-25 2019-10-31 Children's Medical Center Corporation Abcb5 ligands and substrates
US11090412B2 (en) 2018-12-21 2021-08-17 Zavation Medical Products Llc Bone repair composition and kit
US20220184136A1 (en) * 2019-03-28 2022-06-16 Children's Medical Center Corporation Highly functional manufactured abcb5+ mesenchymal stem cells
US20220241339A1 (en) * 2019-04-24 2022-08-04 Children's Medical Center Corporation Abcb5+ stem cell therapeutics for liver disease
CN110314252A (zh) * 2019-05-22 2019-10-11 嘉兴市爵拓科技有限公司 胶原蛋白植入物在制备青光眼手术辅助复原物中的用途
US20230148432A1 (en) * 2020-03-30 2023-05-11 Children's Medical Center Corporation Use of stem cells for treatment of excessive inflammation
GB2605969A (en) * 2021-04-19 2022-10-26 The Griffin Inst Skin membranes

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4280954A (en) 1975-07-15 1981-07-28 Massachusetts Institute Of Technology Crosslinked collagen-mucopolysaccharide composite materials
US4060081A (en) 1975-07-15 1977-11-29 Massachusetts Institute Of Technology Multilayer membrane useful as synthetic skin
BR7908937A (pt) 1978-12-06 1981-06-30 Svedman Paul Dispositivo para tratamento de tecidos,por exemplo,pele
US4505266A (en) 1981-10-26 1985-03-19 Massachusetts Institute Of Technology Method of using a fibrous lattice
GB8509978D0 (en) 1985-04-18 1985-05-30 Juhasz L Wound dressings
US5434075A (en) 1992-03-20 1995-07-18 Board Of Trustees Of The University Of Illinois Monoclonal antibody to a human MDR1 multidrug resistance gene product, and uses
US5837258A (en) 1991-08-30 1998-11-17 University Of South Florida Induction of tissue, bone or cartilage formation using connective tissue growth factor
US6231881B1 (en) 1992-02-24 2001-05-15 Anton-Lewis Usala Medium and matrix for long-term proliferation of cells
GB2272645B8 (en) 1992-11-23 2010-02-10 Johnson & Johnson Medical Wound dressing
GB9403135D0 (en) 1994-02-18 1994-04-06 Univ Glasgow Wound healing device
US5489304A (en) * 1994-04-19 1996-02-06 Brigham & Women's Hospital Method of skin regeneration using a collagen-glycosaminoglycan matrix and cultured epithelial autograft
US5906934A (en) 1995-03-14 1999-05-25 Morphogen Pharmaceuticals, Inc. Mesenchymal stem cells for cartilage repair
ATE439849T1 (de) 1996-04-19 2009-09-15 Osiris Therapeutics Inc Die wiederherstellung und verstärkung von knochen mittels mesenchymalen stammzellen
US5904659A (en) 1997-02-14 1999-05-18 Exogen, Inc. Ultrasonic treatment for wounds
US6152142A (en) 1997-02-28 2000-11-28 Tseng; Scheffer C. G. Grafts made from amniotic membrane; methods of separating, preserving, and using such grafts in surgeries
DE19722075C1 (de) 1997-05-27 1998-10-01 Wilhelm Dr Med Fleischmann Vorrichtung zur Applikation von Wirkstoffen an einer Wundoberfläche
US6355239B1 (en) 1998-03-13 2002-03-12 Osiris Therapeutics, Inc. Uses for non-autologous mesenchymal stem cells
US6368636B1 (en) 1998-03-18 2002-04-09 Osiris Therapeutics, Inc. Mesenchymal stem cells for prevention and treatment of immune responses in transplantation
AU2999199A (en) 1998-04-03 1999-10-25 Osiris Therapeutics, Inc. Mesenchymal stem cells as immunosuppressants
AU4221399A (en) 1998-05-29 1999-12-13 Osiris Therapeutics, Inc. Human cd45+ and/or fibroblast + mesenchymal stem cells
ATE400315T1 (de) 1999-11-29 2008-07-15 Hill Rom Services Inc Vorrichtung zur behandlung einer wunde
US6673606B1 (en) 2000-04-12 2004-01-06 The Children's Hospital Of Philadelphia Therapeutic uses for mesenchymal stromal cells
PT1290028E (pt) 2000-06-05 2010-03-12 Brigham & Womens Hospital Um gene que codifica um homólogo de glicoproteína p humana de resistência a múltiplos fármacos, situado no cromossoma 7p15-21 e suas utilizações
EP1322936A2 (en) 2000-10-03 2003-07-02 California Institute Of Technology Microfluidic devices and methods of use
US6695824B2 (en) 2001-04-16 2004-02-24 The United States Of America As Represented By The Secretary Of The Army Wound dressing system
US6905678B2 (en) 2001-07-07 2005-06-14 Crucell Holland B.V. Gene delivery vectors with cell type specificity for mesenchymal stem cells
US8034904B2 (en) 2002-06-14 2011-10-11 Immunogen Inc. Anti-IGF-I receptor antibody
US20040175366A1 (en) 2003-03-07 2004-09-09 Acell, Inc. Scaffold for cell growth and differentiation
CA3218940A1 (en) 2004-11-12 2006-05-18 Cambridge University Technical Services Ltd. Methods and means related to cancer stem cells
CN105483088B (zh) 2005-10-18 2021-05-28 国家犹太健康中心 条件无限增殖化长期干细胞和制备和使用所述细胞的方法
GB0610778D0 (en) 2006-05-31 2006-07-12 Het Nl Kanker I Phosphatidylinositol phospahte and apoptosis
DK2035549T3 (da) 2006-05-31 2014-10-13 Childrens Medical Center Abcb5-positive mesenkymale stamceller som immunmodulatorer
WO2008064244A2 (en) 2006-11-20 2008-05-29 The Trustees Of Columbia University In The City Of New York Phosphoinositide modulation for the treatment of neurodegenerative diseases
EP2155248B1 (en) 2007-04-12 2015-06-10 The Brigham and Women's Hospital, Inc. Targeting abcb5 for cancer therapy
US9011840B2 (en) * 2008-03-14 2015-04-21 The Board Of Trustees Of The University Of Illinois Activated mesenchymal stem cells for wound healing and impaired tissue regeneration
US11542328B2 (en) 2008-11-14 2023-01-03 The Brigham And Women's Hospital, Inc. Therapeutic and diagnostic methods relating to cancer stem cells
EP3734281A3 (en) 2008-11-14 2021-01-27 The Brigham and Women's Hospital, Inc. Therapeutic and diagnostic methods relating to cancer stem cells
WO2010065711A1 (en) 2008-12-04 2010-06-10 Adimab, Inc. An abcb5 epitope and antibodies thereto for the treatment of cancer
GB0908927D0 (en) 2009-05-22 2009-07-01 Univ Reading The Synthetic graft
WO2011087743A2 (en) * 2009-12-22 2011-07-21 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Decellularized adipose cell growth scaffold
WO2013002953A1 (en) * 2011-06-01 2013-01-03 The Board Of Trustees Of The University Of Illinois Membrane-scaffold composites for tissue engineering applications
KR101138091B1 (ko) 2011-08-31 2012-04-24 세원셀론텍(주) 중간엽 줄기세포 기본 배양 배지 조성방법, 중간엽 줄기세포 기본 배양 배지 및 이를 이용하여 배양분화된 세포치료제
DK2964238T3 (da) 2013-02-19 2021-03-22 Childrens Medical Center Abcb5(+) stem cells for treating ocular disease
KR102319899B1 (ko) 2013-05-10 2021-11-01 칠드런'즈 메디컬 센터 코포레이션 상처 치유 및 조직 공학
WO2016179576A1 (en) 2015-05-07 2016-11-10 Bioxcel Corporation Novel immunomodulatory therapeutic strategies targeting tumors in cancer
WO2019210109A1 (en) 2018-04-25 2019-10-31 Children's Medical Center Corporation Abcb5 ligands and substrates
US20220184136A1 (en) 2019-03-28 2022-06-16 Children's Medical Center Corporation Highly functional manufactured abcb5+ mesenchymal stem cells

Similar Documents

Publication Publication Date Title
JP2016520068A5 (cg-RX-API-DMAC7.html)
Vig et al. Advances in skin regeneration using tissue engineering
Ilic et al. Human amniotic membrane grafts in therapy of chronic non-healing wounds
Cerqueira et al. Human adipose stem cells cell sheet constructs impact epidermal morphogenesis in full-thickness excisional wounds
Swartzlander et al. Immunomodulation by mesenchymal stem cells combats the foreign body response to cell-laden synthetic hydrogels
Rennert et al. Biological therapies for the treatment of cutaneous wounds: phase III and launched therapies
Ingraldi et al. The preparation and clinical efficacy of amnion-derived membranes: a review
IL320440A (en) Methods of in vitro differentiation of midbrain dopamine (mda) neurons
WO2014040026A3 (en) Amniotic membrane and its use in wound healing and tissue engineering constructs
CU24495B1 (es) Compuestos que expanden las células hematopoyéticas y método ex vivo para expandir las células hematopoyéticas
CL2008001620A1 (es) Induccion de fenotipo tolerogenico en celulas dendriticas maduras
AR081166A1 (es) Angiogenesis por el uso de celulas madre placentarias
Fitriani et al. Application of amniotic membrane in skin regeneration
RU2017111686A (ru) Искусственная роговица, полученная путем трехмерной биопечати
BR112015028193A2 (pt) cicatrização de feridas e engenharia de tecidos
CO2021003290A2 (es) Método para obtener una población enriquecida de células madre mesenquimales funcionales, células obtenidas de la misma y composiciones que las comprenden.
JP2016536315A5 (cg-RX-API-DMAC7.html)
MX2016005824A (es) Metodo de cultivo celular.
MX377300B (es) Terapia con células madre en patologías endometriales.
Ozdogan et al. An in vitro 3D diabetic human skin model from diabetic primary cells
EP4055145A4 (en) USE OF VETO CELLS TO TREAT SICKLE CELL ANEMIA
MX2021012141A (es) Composicion para regeneracion de tejidos, metodo de produccion y usos de la misma.
Mahapatra et al. Bioinspired Silk and Human Amniotic Membrane-Based MSC-sEV-Functionalized Wound Dressing Enhances Skin Regeneration: A Cell-Free Therapeutic Modality for Wound Care
EA201200028A1 (ru) Альфа-1 мультимеры hla-g и их фармацевтическое применение
AR110634A1 (es) Método para preparar un suplemento a partir de cultivos de células mesenquimales de gelatina de wharton y usos del mismo